Position in IDXX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$383,248
+$155,840 QoQ
Shares Held
728
+71.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#836
of 1,286 holders
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Proficio Capital Partners LLC holds $4,469,091 across 9 Diagnostics & Research names. IDXX ranks #6 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
5,353 | $941,217 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,412 | $707,920 | |
| 3 | NTRA |
Natera, Inc.
|
2,272 | $616,734 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
910 | $481,926 | |
| 5 | DHR |
Danaher Corp /De/
|
2,381 | $453,532 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
This page
|
728 | $383,248 | |
| 7 | A |
Agilent Technologies, Inc.
|
2,854 | $379,096 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,566 | $302,582 |
All Filings in IDXX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $383,248 | 728 | Shares | Sole | 2026-08-17 | |
| 2025-06-30 | $227,408 | 424 | Shares | Sole | 2025-08-07 | |
| 2021-12-31 | $205,439 | 312 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $230,103 | 370 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $241,883 | 383 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||